Skip to content

OMNIPHARMA

Absorbed by MULTIPHARMA on 06-12-2018 KBO/BCE: BE 0449.138.407

Timeline

37 events since 1993
2019
Merger: absorbed by MULTIPHARMADissolution of the company · Dissolved without liquidation · MULTIPHARMA holds all the shares · General meeting of 06-12-20185 points ▸
  • General meeting of 06-12-2018
  • Merger by absorption
  • MULTIPHARMA holds all the shares
  • The operation takes effect in the accounts on 01-09-2018
  • Power of attorney granted to
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

2018
Merger proposal: to be absorbed by MULTIPHARMABoard meeting of 20-09-20183 points ▸
  • Merger by absorption
  • Board meeting of 20-09-2018
  • The operation takes effect in the accounts on 01-09-2018
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2017 filed PDFabbreviated format · 14 days late
2017
Back to profit net €5,081 The net result is €5,081, after 3 loss-making years.
Registered office moved to AnderlechtThe registered office moved to Square Marie Curie 30 te 1070 Anderlecht · , and resign · and act as permanent representatives · General meeting of 13-11-201713 points ▸
  • General meeting of 13-11-2017
  • resigns as manager
  • resigns as manager
  • resigns as manager
  • acts as permanent representative
  • Discharge granted to
  • Discharge granted to
  • Discharge granted to
  • appointed as manager
  • appointed as statutory auditor
  • acts as permanent representative
  • Board meeting of 13-11-2017
  • The registered office moved to Square Marie Curie 30 te 1070 Anderlecht

Open the deed in the Belgian Official Gazette

Annual accounts 2016 filed PDFabbreviated format · 73 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 61 days before the deadline
appointed as manager acts as permanent representative · General meeting of 27-03-20163 points ▸
  • General meeting of 27-03-2016
  • appointed as manager
  • acts as permanent representative

Open the deed in the Belgian Official Gazette

2015
Annual accounts 2014 filed PDFabbreviated format · 30 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 49 days before the deadline
2013
Demerger: OMNIPHARMA splits off to KEMPS PHARMAFounding capital of €51,848.49 · Capital decrease of €125,383.36 to €34,103.33 · The capital fell from €159,486.69 to €34,103.33 · (manager) and (manager) appointed · General meeting of 22-08-201312 points ▸
  • General meeting of 22-08-2013
  • appointed as manager
  • appointed as manager
  • The founding capital is €51,848.49, divided into 3,150 shares
  • holds 1,050 shares
  • holds 1,050 shares
  • holds 1,050 shares
  • The capital is €59,479.50, divided into 3,150 shares
  • The operation takes effect in the accounts on 01-01-2013
  • The capital was reduced by €125,383.36
  • The capital is €20,000, divided into 3,150 shares
  • holds 1,050 shares
  • The deed holds 19 more points.

Open the deed in the Belgian Official Gazette

Demerger proposal: OMNIPHARMA splits off to KPD PHARMA (manager) and (manager) appointed · holds 1,050 shares · holds 1,050 shares12 points ▸
  • The operation takes effect in the accounts on 01-01-2013
  • is in office as manager
  • is in office as manager
  • holds 1,050 shares
  • holds 1,050 shares
  • holds 1,050 shares
  • The capital is €159,487, divided into 3,150 shares
  • The capital is €14,055.37, divided into 3,150 shares
  • appointed as manager
  • appointed as manager
  • The capital is €51,848.49, divided into 3,150 shares
  • The founding capital is €59,479.50, divided into 3,150 shares
  • The deed holds 33 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2012 filed PDFabbreviated format · 40 days before the deadline
2012
Back to profit net €1.4m The net result is €1.4m, after one loss-making year.
Equity above €500,000 equity €552,839 Equity rises from -€1.0m to €552,839.
Annual accounts 2011 filed PDFabbreviated format · 56 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 62 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 54 days before the deadline
2009
Annual accounts 2008 filed PDFabbreviated format · 64 days before the deadline
2008
Back to profit net €74,212 The net result is €74,212, after one loss-making year.
Annual accounts 2007 filed PDFabbreviated format · 59 days before the deadline
2007
Weakest financial year net -€681,576 The net result drops to -€681,576, the lowest from 2006 to 2017.
Annual accounts 2006 filed PDFabbreviated format · 60 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
Annual accounts 2002 filed PDFabbreviated format
2002
Annual accounts 2001 filed PDFabbreviated format
2001
Annual accounts 2000 filed PDFabbreviated format
2000
Annual accounts 1999 filed PDFabbreviated format
1999
Annual accounts 1998 filed PDFabbreviated format
1998
Annual accounts 1997 filed NBBabbreviated format
1997
Annual accounts 1996 filed NBBabbreviated format
1996
Annual accounts 1995 filed NBBabbreviated format
1995
Annual accounts 1994 filed NBBabbreviated format
1994
Annual accounts 1993 filed NBBabbreviated format
1993
Incorporation 24 publications in the Belgian Official Gazette, the last on 03-01-2019

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

In 2017 the registered office moved to Anderlecht.1 OMNIPHARMA has filed 25 sets of annual accounts, the latest for financial year 2017.2 In 2018 the company was absorbed by merger into MULTIPHARMA.3

  1. 1Belgian Official Gazette, 22-12-2017
  2. 2National Bank, annual accounts 2017
  3. 3Belgian Official Gazette, 03-01-2019